India to United States: Paracetamol Export Trade Route
India has recorded 156 verified shipments of Paracetamol exported to United States, representing a combined trade value of $69.4K USD. This corridor is served by 12 active Indian exporters, with an average shipment value of $445 USD. The leading Indian exporter is MEDOPHARM PRIVATE LIMITED, which accounts for 65% of total export value with 2 shipments worth $45.3K USD. On the buying side, BLESSINGS INTERNATIONAL is the largest importer in United States with $62.7K USD in purchases. The top 3 suppliers — MEDOPHARM PRIVATE LIMITED, MEDO PHARM PRIVATE LIMITED, KALINDI OVERSEAS — together control 98% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Paracetamol corridor is one of India's established pharmaceutical export routes, with 156 shipments documented worth a combined $69.4K USD. The route is dominated by MEDOPHARM PRIVATE LIMITED, which alone accounts for roughly 65% of all export value, reflecting the consolidated nature of India's paracetamol manufacturing sector.
Across 12 active suppliers, the average shipment value stands at $445 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (0%) and air (100%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October-December, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 26.1%, placing it at rank #3 among India's top paracetamol export destinations globally.
On the import side, key buyers of Indian paracetamol in United States include BLESSINGS INTERNATIONAL, THE PURCHASE DEPARTMENT, UNITED AMERICA GROUP LLC and 91 others. BLESSINGS INTERNATIONAL is the single largest importer with 3 shipments valued at $62.7K USD.
